Reinke Emily N, Reynolds Joe, Gilmour Nicola, Reynolds Georgia, Strickland Judy, Germolec Dori, Allen David G, Maxwell Gavin, Kleinstreuer Nicole C
Inotiv, Inc., Morrisville, NC 27560, USA.
Unilever Safety and Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedforshire MK44 1LQ, United Kingdom.
Curr Res Toxicol. 2024 Dec 14;8:100205. doi: 10.1016/j.crtox.2024.100205. eCollection 2025.
Mechanistically based non-animal methods for assessing skin sensitization hazard have been developed, but are not considered sufficient, individually, to conclusively define the skin sensitization potential or potency of a chemical. This resulted in the development of defined approaches (DAs), as documented in OECD TG 497, for combining information sources in a prescriptive manner to provide a determination of risk or potency. However, there are currently no DAs within OECD TG 497 that can derive a point of departure (POD) for risk assessment. The Skin Allergy Risk Assessment - Integrated Chemical Environment (SARA-ICE) DA for skin sensitization is a Bayesian statistical model that estimates a human-relevant metric of sensitizer potency, the ED, an estimate of the human predictive patch test dermal dose at which there is 1% chance of inducing sensitization, which can be used in a risk assessment paradigm. The model accounts for variability of input data and explicitly quantifies uncertainty. SARA-ICE derives the ED from a variety of and test method data and is built upon historical human, murine, and test data for 434 chemicals. In addition to the ED POD SARA-ICE DA also provides a Globally Harmonized System of Classification and Labelling of Chemicals (GHS) classification probability for GHS subcategories 1A, 1B and not classified (NC). Here we describe the SARA-ICE model and its evaluation, including performance versus benchmark PODs. In addition, via a case study with isothiazolinones (ITs), we demonstrate the utility of SARA-ICE for integrating different data inputs and compare the ED for six ITs to existing historical data.
已经开发出基于机制的非动物方法来评估皮肤致敏危害,但单独使用这些方法被认为不足以最终确定化学品的皮肤致敏潜力或强度。这导致了规定方法(DAs)的发展,如经合组织测试指南497中所述,以规定的方式组合信息来源,以确定风险或强度。然而,经合组织测试指南497目前没有能够得出风险评估起点(POD)的规定方法。皮肤过敏风险评估 - 综合化学环境(SARA - ICE)皮肤致敏规定方法是一种贝叶斯统计模型,它估计致敏剂强度的人类相关指标ED,即估计人类预测性斑贴试验皮肤剂量,在该剂量下诱导致敏的可能性为1%,可用于风险评估范式。该模型考虑了输入数据的变异性并明确量化不确定性。SARA - ICE从各种体内和体外测试方法数据中得出ED,并基于434种化学品的历史人类、小鼠和体外测试数据构建。除了ED POD外,SARA - ICE规定方法还提供了全球化学品统一分类和标签制度(GHS)1A、1B和未分类(NC)子类别的分类概率。在此,我们描述SARA - ICE模型及其评估,包括与基准PODs相比的性能。此外,通过异噻唑啉酮(ITs)的案例研究,我们展示了SARA - ICE在整合不同数据输入方面的效用,并将六种ITs的ED与现有历史数据进行比较。